Clinical trial
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
NCT06833463 is registered in ClinicalTrials.gov with Chiesi Poland Sp. z o.o. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
- Lead sponsor
- Chiesi Poland Sp. z o.o.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 29, 2025
- Completion date
- January 30, 2028
- Enrollment
- 120 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant